AMGN250117P242500
- 0.13
- 0.000.00%
Amgen Newsroom
Analyst Expectations For Amgen's Future
Today's Analyst Rating | Amazon Price Target Raised to $280 by Wedbush, ServiceNow Price Target Raised to $1432 by Citi
Jan 28, Wall Street analysts have updated their stock ratings today including $Amazon(AMZN.US)$ and $ServiceNow(NOW.US)$.
Citi Maintains Amgen(AMGN.US) With Hold Rating, Cuts Target Price to $295
Amgen Is Maintained at Neutral by Citigroup
Express News | Amgen Inc : Citigroup Cuts Target Price to $295 From $310
Drug Companies Raise Prices on More Than 800 Drugs in January -- WSJ
This Is What Whales Are Betting On Amgen
Shareholders Should Be Pleased With Amgen Inc.'s (NASDAQ:AMGN) Price
Unusual Options Activity: NVDA, BIDU and Others Attract Market Bets, NVDA V/OI Ratio Reaches 3000.0
EST Jan 24th Closing Delivery - In the last three hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options
Janux Therapeutics Promotes Zachariah McIver to Chief Medical Officer
Amgen Analyst Ratings
RBC Capital Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $324
Allurion (ALUR.US) stock price surged violently; its new weight loss therapy can maintain muscle mass.
On Thursday, Allurion's stock price soared 80% in after-hours trading, following reports that the company plans to conduct clinical research combining its gastric balloon weight loss product with GLP-1 drugs.
Allurion Stock Soars 70% on Weight-loss Therapy Update
Cytokinetics Heart Drug's Future Sparks Optimism Despite M&A Hurdles and Royalty Deal Concerns: Analyst
DeCODE Genetics: Complete Recombination Map of the Human-genome, a Major Step in Genetics
GLP-1 Drugs Cut Risk of Alzheimer's, NVO & LLY Shares Rise
Wells Fargo Maintains Amgen(AMGN.US) With Hold Rating, Maintains Target Price $280
Amgen's Lumakras Gets FDA Nod for Expanded Use in Colorectal Cancer
Here's Why Amgen Inc. (AMGN) Is Among the Highest Yielding Dividend Stocks In the Dow